Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hunan Xunda Pharmaceutical is a Chinese pharmaceutical company that specializes in the research, development, and large-scale production of active pharmaceutical ingredients (APIs) and finished drug products. Founded in 1995 and based in Xiangtan, Hunan, the company has built a significant reputation for its expertise in macrolide antibiotics and cardiovascular medications. Its manufacturing infrastructure includes multiple production lines that adhere to international Good Manufacturing Practice (GMP) standards, ensuring high-quality output for global distribution. Xunda Pharma serves a diverse clientele by providing essential generic medicines and chemical intermediates to markets across Asia, Europe, and the Americas. The company's integrated business model allows it to maintain control over the entire lifecycle of its products, from initial synthesis to commercial sales.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Xunda Pharma.